REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH AML FROM 65 TO 74 YEARS UNFIT FOR FIRST-LINE INTENSIVE CHEMOTHERAPY IN JAPAN.

EHA Library, Fumiaki Fujii, 4160612

PROGNOSTIC IMPACT OF THE AML60+ SCORE FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH HYPOMETHYLATING AGENTS

EHA Library, Tobias Silzle, 4160615

CLINICAL EXPERIENCE WITH HDAC INHIBITOR-BASED PROTOCOLS IN MECOM-REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Eitan Kugler, 4160618

REAL-LIFE STUDY ON GILTERITINIB RELATED INFECTIONS (GILTERINF): AN ITALIAN SEIFEM STUDY

EHA Library, Elisa Buzzatti, 4160619

OUTCOMES OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ACUTE MYELOID LEUKEMIA: THE THREE-SITE MAYO CLINIC CANCER CENTER EXPERIENCE.

EHA Library, Jabra Zarka, 4160620

VA COMBINED WITH LIPOSOMAL MITOXANTRONE: A NOVEL AND SAFE INDUCTION THERAPY FOR NEWLY DIAGNOSED AML

EHA Library, Yan Yu, 4160621

EFFECT OF OBESITY ON OVERALL SURVIVAL IN ELDERLY PATIENTS (>65 YEARS OLD) WITH ACUTE MYELOID LEUKEMIA - SINGLE-CENTER EXPERIENCE.

EHA Library, Karolina Bełdzińska, 4160622

RELATIONSHIP BETWEEN SALVAGE STRATEGIES AND OUTCOMES IN REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA AFTER FIRST-LINE INTENSIVE CHEMOTHERAPY

EHA Library, Lucas Lefèvre, 4160623

THE PREDICTIVE ROLE OF HEMATOLOGIC RECOVERY IN THE PROGNOSIS OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH AZACITIDINE-VENETOCLAX

EHA Library, Yan Li, 4160624

CLINICAL EFFICACY AND SAFETY OF VENETOCLAX COMBINED WITH HOMOHARRINGTONINE, AZACITIDINE, AND CYTARABINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Xin Yan, 4160625

IN-DEPTH IMMUNE AND METABOLIC PROFILING OF GAIA/CLL13 PATIENTS TO UNCOVER TREATMENT-SPECIFIC CHANGES TO THE T-CELL COMPARTMENT [CJ1]

EHA Library, Chaja F Jacobs, 4160626

THE LANDSCAPE OF CLONAL HEMATOPOIESIS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Othman Al-Sawaf, 4160629

EGR2 MUTATIONS COOPERATE IN ACTIVATING NOTCH-1 PATHWAY AND LEAD TO BTK INHIBITORS RESISTANCE IN CLL

EHA Library, Alessia Morabito, 4160630

DIAGNOSTIC CRITERIA FOR NK-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA: VALIDATION THROUGH A MULTICENTRIC INTERNATIONAL STUDY

EHA Library, Thierry Lamy, 4160631

A CLINICAL-MOLECULAR MODEL FOR A PERSONALISED PREDICTION OF TIME TO FIRST TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Aleix Real, 4160632

CONTROLLED PERFUSION OF A VASCULARIZED SCAFFOLD WITHIN A 3D PRINTED BIOREACTOR TO STUDY CLL CELLS TRAFFICKING

EHA Library, Riccardo Pinos, 4160634

IMPACT OF TUMOR BURDEN AND PRIOR VENETOCLAX TREATMENT ON MOSUNETUZUMAB-MEDIATED TUMOR CONTROL IN RELAPSED/REFRACTORY CLL

EHA Library, Hyun Yong Jin, 4160635

GENOMIC CHARACTERIZATION OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH TP53 ALTERATIONS FROM A SPANISH REAL-WORLD COHORT TREATED WITH TARGETED AGENTS

EHA Library, Joanna Kamaso, 4160636

UNCOVERING A CRITICAL ROLE FOR VAV1 IN α4ß1-BCR CROSSTALK IN CHRONIC LYMPHOCYTIC LEUKAEMIA: NOVEL INSIGHTS INTO DISEASE MECHANISMS

EHA Library, Tahera Alnassfan, 4160637

VENETOCLAX-ACALABRUTINIB FOR CLL PATIENTS RELAPSING AFTER VENETOCLAX-ANTICD20 TREATMENT: HIGHLY EFFECTIVE AND LOW TOXICITY. INTERIM ANALYSIS OF HOVON 159/REVEAL PHASE 2 TRIAL

EHA Library, Sabina Kersting, 4160638

ALLOGENEIC STEM CELL TRANSPLANTATION IS EFFECTIVE AFTER PATHWAY INHIBITOR TREATMENTS IN CLL; A RETROSPECTIVE STUDY ON BEHALF OF THE CHRONIC MALIGNANCIES WORKING PARTY OF THE EBMT

EHA Library, Michel van Gelder, 4160639

SEQUOIA 5-YEAR FOLLOW-UP IN ARM C: FRONTLINE ZANUBRUTINIB MONOTHERAPY IN PATIENTS WITH DEL(17P) AND TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)

EHA Library, Mazyar Shadman, 4160640

COMBINATION OF ZANUBRUTINIB + VENETOCLAX FOR TREATMENT-NAIVE CLL/SLL: RESULTS IN SEQUOIA ARM D

EHA Library, Mazyar Shadman, 4160641

MRD GUIDED MESUTOCLAX PLUS ORELABRUTINIB FOR CLL/SLL DEMONSTRATES HIGH RESPONSE AND EARLY MRD CLEARANCE WITH GOOD TOLERABILITY: PRELIMINARY ANALYSIS FROM AN ONGOING PHASE II DOSE OPTIMIZATION STUDY

EHA Library, Yang Liang, 4160642

USING MINIMAL RESIDUAL DISEASE STATUS TO GUIDE VENETOCLAX TREATMENT DURATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: INTERIM RESULTS FROM THE PHASE II VENETOSTOP STUDY

EHA Library, Leora Boussi, 4160643

SERIOUS INFECTIONS IN PATIENTS WITH CLL/SLL TREATED WITH COMBINATION VENETOCLAX AND OBINUTUZUMAB COMPARED WITH THOSE TREATED WITH ZANUBRUTINIB: A REAL-WORLD STUDY

EHA Library, Nicole Lamanna, 4160646

PHASE 1 STUDY OF FCN-338, A NOVEL BCL-2 INHIBITOR IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA: SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY

EHA Library, Huiqiang Huang, 4160650

IMPACT OF IBRUTINIB ON QUALITY OF LIFE IN PATIENTS WITH EARLY-STAGE, ASYMPTOMATIC CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM THE PHASE III CLL12 TRIAL - MATCHING SAFETY TO PATIENT-REPORTED OUTCOMES

EHA Library, Ellinor Goergen, 4160651

DEVELOPMENT OF A CLINICAL MACHINE LEARNING TOOL FOR THE PREDICTION OF AUTOIMMUNE HEMOLYTIC ANEMIA IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION BASED MULTILAYER PERCEPTRON MODEL

EHA Library, Rayan Ramadan, 4160652

COMPARATIVE EFFICACY OF ZANUBRUTINIB VERSUS FIXED-DURATION ACALABRUTINIB PLUS VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)

EHA Library, Talha Munir, 4160656

GENOTYPING OF SLC22A4 SNP RS460089 IN A REAL-LIFE CML COHORT: IMPLICATIONS FOR IMATINIB RESPONSE AND STABLE DMR ACHIEVEMENT

EHA Library, Katerina Machova, 4160657

LOW SERUM IL-8 MAY CONTRIBUTES TO TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA

EHA Library, Yuki Fujioka, 4160659

GERMLINE VARIANTS IN PEDIATRIC CHRONIC MYELOID LEUKEMIA

EHA Library, Tabita Ghete, 4160660

EARLY PREDICTION OF MR4.5 ATTAINMENT AND SUSTAINED RESPONSE IN CHRONIC MYELOID LEUKEMIA TREATED WITH SECOND-GENERATION TYROSINE KINASE INHIBITORS: ANALYSIS FROM THE JALSG CML212 ROAD TO MR4.5 STUDY

EHA Library, TAKAAKI ONO, 4160661

PROSPECTIVE VALIDATION OF A DNA/RNA MRD-BASED RISK STRATIFICATION MODEL DURING TWO-PHASE TKI DOSE DE-ESCALATION FOR DISCONTINUATION IN CML

EHA Library, Katerina Machova, 4160662

IMPROVED PATIENT-REPORTED OUTCOMES (PROS) WITH ASCIMINIB (ASC) VS INVESTIGATOR-SELECTED TYROSINE KINASE INHIBITORS (IS-TKIS) IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML): ASC4FIRST WK 48 ANALYSIS

EHA Library, Andreas Hochhaus, 4160663

RESULTS FROM THE FIRST-IN-CHILD PHASE II TRIAL (ITCC-054/COG-AAML1921) OF BOSUTINIB IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED (ND) CHRONIC MYELOID LEUKEMIA (CML).

EHA Library, Kim Schellekens, 4160664

ASSESSMENT OF TRANSITIONING FROM HIGH-POTENCY TO LOW-POTENCY INHIBITORS IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DOWNGRADING-IMPACT (D-IMPACT) PROJECT, A CML CAMPUS STUDY

EHA Library, Simona Bernardi, 4160665

THE FRONTLINE SECOND GENERATION TYROSINE KINASE INHIBITORS BRING TREATMENT-FREE REMISSION TO MORE PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Naoto Takahashi, 4160666

ASC4OPT STUDY: HIGH EFFICACY AND FAVORABLE TOLERABILITY OF ASCIMINIB ONCE OR TWICE DAILY IN CML PATIENTS WITH SUBOPTIMAL RESPONSE, RESISTANCE OR INTOLERANCE OF 2 OR MORE TYROSINE KINASE INHIBITORS

EHA Library, Andreas Hochhaus, 4160668

SINGLE-CELL DERIVED TRANSCRIPTIONAL SIGNATURE OF DYSERYTHROPOIESIS STRATIFIES MDS WITH DIFFERENTIAL OUTCOMES AND RESPONSE TO LUSPATERCEPT

EHA Library, Kristian Gurashi, 4160675

TREATMENT ASSOCIATED CLONAL EVOLUTION IN HR-MDS AND AML- COMPREHENSIVE PROFILING IDENTIFIES BIOMARKERS AND TARGETABLE MECHANISMS OF ESCAPE

EHA Library, Paolo Mazzeo, 4160676

SOMATIC RUNX1 DELETIONS IN MYELODYSPLASTIC SYNDROME: A NOVEL RARE RECURRENT GENETIC ABERRATION ASSOCIATED WITH HIGH-RISK FOR TRANSFORMATION TO ACUTE MYELOID LEUKEMIA

EHA Library, Ahmed Al-Djaber, 4160679

SURVIVAL TRENDS AND HEALTHCARE UTILIZATION COSTS IN ACUTE MYELOID LEUKEMIA IN 2007-2022 AT THE HELSINKI UNIVERSITY HOSPITAL

EHA Library, Theerin Lanamtieng, 4161367

EFFECTS OF A SUPPORTIVE ONCOLOGY CARE AT HOME INTERVENTION ON HEALTH CARE UTILIZATION IN PATIENTS WITH NON-HODGKIN LYMPHOMA: SUBGROUP ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL

EHA Library, P. Connor Johnson, 4161370

ACCESS TO SUTIMLIMAB FOR COLD AGGLUTININ DISEASE THROUGH THE ORPHAN DRUG ACCESS PROTOCOL IN THE NETHERLANDS: INSIGHTS FROM THE FIRST YEAR

EHA Library, Kathelijn Verdeyen, 4161375

UNSUPERVISED DEEP LEARNING REVEALS HISTOLOGICAL MOTIFS IN CD34-STAINED BONE MARROW TREPHINES OF MYELOID NEOPLASMS

EHA Library, Carlo Pescia, 4161382

NEXT GENERATION SEQUENCING FOR MINIMAL RESIDUAL DISEASE DETECTION AND MONITORING IN MULTIPLE MYELOMA: ANALYSIS OF FEASIBILITY IN DAILY PRACTICE.

EHA Library, Silvia ARMUZZI, 4161383

HIGHLY MULTIPLEXED 2D AND 3D IMAGING UNCOVERS LEUKEMIA-INDUCED IMMUNE DYSREGULATION AND HEMATOPOIETIC DISRUPTION IN THE BONE MARROW MICROENVIRONMENT

EHA Library, Lanzhu Li, 4161386

PDT: A NOVEL DIAGNOSIS AND TREATMENT OPTION GENERATION ARCHITECTURE FOR RARE DISEASE

EHA Library, Xue Shi, 4161387

ACCURATE AND RELIABLE DETECTION OF CLONAL HEMATOPOIESIS IN PLASMA CELL-FREE DNA

EHA Library, Alyssa Parker, 4161389

ASSESSING THE UTILITY OF NGS-DETECTED CNVS AS AN ALTERNATIVE TO FISH FOR CYTOGENETIC ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ana Gea Peña, 4161390

IMMUNOTHERAPY OF DRUG-RESISTANT HEMATOLOGIC MALIGNANCIES WITH CURE POTENTIAL BY SIMULTANEOUS TARGETING IL-2 PRE-ACTIVATED MISMATCHED T, NK & NKT CELLS AGAINST DETECTABLE CELL SURFACE CANCER ANTIGENS

EHA Library, Shimon Slavin, 4161391

AI-DRIVEN AUTOMATED LYMPHOCYTE PROFILING AND CAR-T CELL MONITORING FOR SCALABLE IMMUNOTHERAPY DIAGNOSTICS: THE SMARTCYTOFLOW PROJECT

EHA Library, Adrian Mosquera Orgeira, 4161392

GENEXUS: AN ALL-IN-ONE APPROACH OF NEXT GENERATION SEQUENCING IN THE MOLECULAR DIAGNOSIS OF ACUTE MYELOID LEUKEMIA

EHA Library, Alessandra Potenza, 4161393

LYM-SYNGAN: ENHANCING CT-TO-PET MEDICAL IMAGE SYNTHESIS FOR LYMPHOMA USING A GENERATIVE ADVERSARIAL NETWORK WITH MULTI-LEVEL LINEAR ATTENTION AND EFFICIENT VISION TRANSFORMER

EHA Library, xiangyan Feng, 4161394

LIMITATIONS OF AI-ASSISTED DIGITAL IMAGING IN DETECTING AND QUANTIFYING CIRCULATING PLASMA CELLS

EHA Library, Iona Stylianides, 4161395

OPTICAL GENOME MAPPING IS A POWERFUL DIAGNOSTIC TOOL IN NON-HODGKIN LYMPHOMA

EHA Library, Amber Verhasselt, 4161397

EXPLORING THE BELGIAN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) POPULATION THROUGH AI AND DIGITAL TECHNOLOGIES: INSIGHTS FROM THE BE-CLLEAR STUDY

EHA Library, Ann Debecker, 4161400

THE FUS::ERG FUSION IN ACUTE MYELOID LEUKEMIA: INSIGHTS INTO MOLECULAR PROFILES AND PROGNOSTIC IMPLICATIONS

EHA Library, Bingbing Han, 4160613

HEALTHCARE RESOURCE UTILIZATION IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX COMPARED TO HIGH- AND LOW-INTENSITY NON-VENETOCLAX THERAPIES

EHA Library, Pinkal Desai, 4160614

OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND AZACITIDINE IN REAL-WORLD BELGIAN CLINICAL PRACTICE

EHA Library, Adrien DE VOEGHT, 4160616

SURVIVAL ANALYSIS OF LONG-TERM TREATMENT WITH VENETOCLAX-AZACITIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: MULTICENTRE REAL-WORLD OUTCOMES IN CHINA

EHA Library, Jing Zou, 4160617

GUT MICROBIOME IMBALANCE DRIVES IMMUNE EXHAUSTION VIA SHORT-CHAIN FATTY ACIDS IN CLL

EHA Library, Monika Szelest, 4160628

UNVEILING STAT3-DRIVEN CIRCULAR RNAS ALTERATIONS IN T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA (T-LGLL)

EHA Library, Elisa Rampazzo, 4160633

A PHASE 1 STUDY OF SGR-1505, AN ORAL, POTENT MALT1 INHIBITOR FOR RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES, INCLUDING CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)

EHA Library, Stephen Spurgeon, 4160644

10-YEAR FOLLOW-UP OF A RANDOMIZED PHASE-2 STUDY OF IBRUTINIB OR IBRUTINIB PLUS RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Jan Burger, 4160645

REAL-WORLD COMPARATIVE EFFECTIVENESS OF VENETOCLAX-OBINUTUZUMAB VERSUS SECOND-GENERATION BRUTON TYROSINE KINASE INHIBITORS IN FRONTLINE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Beenish Manzoor, 4160647

TREATMENT EFFECTIVENESS IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING VENETOCLAX-BASED THERAPY AFTER PROGRESSION ON A COVALENT BRUTON TYROSINE KINASE INHIBITOR (CBTKI)

EHA Library, Beenish Manzoor, 4160648

ANALYSIS OF COVID-19 INFECTIONS WITH FIXED-DURATION ACALABRUTINIB-VENETOCLAX COMBINATIONS IN TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA IN THE PHASE 3 AMPLIFY TRIAL

EHA Library, Jennifer Brown, 4160649

REAL-WORLD COMPARATIVE EFFECTIVENESS OF FIRST-LINE BRUTON TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ryan Jacobs, 4160653

FIRST WORLDWIDE REAL-LIFE DATA ON FIXED-DURATION IBRUTINIB+VENETOCLAX TREATMENT FOR PREVIOUSLY UNTREATED CLL/SLL PATIENTS: INITIAL INTERIM ANALYSIS OF SPAIN´S LI+VE OBSERVATIONAL STUDY

EHA Library, JOSE ANGEL HERNANDEZ RIVAS, 4160654

FIXED-DURATION BTKI-VENETOCLAX COMBINATIONS IN CLL: AN INDIRECT COMPARISON OF AMPLIFY AND CAPTIVATE TRIALS

EHA Library, stefano molica, 4160655

OVERCOMING ASCIMINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA WITH IDENTIFICATION OF THERAPEUTIC STRATEGIES TARGETING BCR::ABL1 MUTATIONS

EHA Library, Seiichi Okabe, 4160658

MYELOPROLIFERATIVE NEOPLASMS WITH CONCOMITANT CHRONIC MYELOID LEUKAEMIA ARE ASSOCIATED WITH TKI RESISTANCE AND POOR OUTCOMES: A REVIEW OF 46 CASES

EHA Library, Laura Li Gagnon, 4160667

UPDATED RESULTS OF MANAGED-ACCESS PROGRAM (MAP) OF ASCIMINIB USE IN CHRONIC MYELOID LEUKEMIA PATIENTS IN 3 CLINICAL CENTERS.

EHA Library, Ekaterina Chelysheva, 4160669

IMPACT OF ADVERSE EVENTS ON QUALITY OF LIFE IN CHRONIC MYELOID LEUKEMIA (CML) - RESULTS FROM THE PATIENT SURVEY ON HUMANISTIC BURDEN OF INTOLERANCE TO FIRST OR SECOND TKIS (SHIFT) STUDY IN THE US

EHA Library, David Wei, 4160670

CLINICAL FEATURES AND T CELL REPERTOIRE OF CHRONIC MYELOID LEUKEMIA PATIENTS WHO ATTEMPT DISCONTINUATION OF TYROSINE KINASE INHIBITORS: THE ISAC-TFR STUDY

EHA Library, Mai Fujita, 4160671

DEVELOPMENT OF A NOVEL SCORING TOOL TO PREDICT OPTIMAL RESPONSE IN CHRONIC MYELOID LEUKEMIA FOR IMPROVING TREATMENT EFFICACY BEYOND CURRENT RISK CLASSIFICATIONS

EHA Library, Kohjin Suzuki, 4160672

IMPACT OF PONATINIB TREATMENT ON PREGNANCY OUTCOMES

EHA Library, Elisabetta Abruzzese, 4160673

ANALYSIS OF FACTORS INFLUENCING TREATMENT-FREE REMISSION OUTCOMES AFTER IMATINIB DISCONTINUATION IN PAEDIATRIC CHRONIC MYELOID LEUKEMIA

EHA Library, Yanli Zhang, 4160674

GALECTIN-1 AS A POTENTIAL NOVEL THERAPEUTIC TARGET IN CHRONIC MYELOMONOCYTIC LEUKAEMIA

EHA Library, Laura Guest, 4160677

SELECTIVE ASO-BASED JAK2 INHIBITOR FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH JAK2 V617F MUTATION BURDEN

EHA Library, Sandra Smieszek, 4160678

THE ECONOMIC IMPACT OF TREATMENT SEQUENCES FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN ITALY: A COST OF CARE SEQUENCING MODEL FOR PATIENTS WITH CLL

EHA Library, Andrea Visentin, 4161368

ECONOMIC BURDEN OF CYTOPENIA IN PATIENTS WITH MYELOFIBROSIS: ANALYSIS OF A US NATIONAL ADMINISTRATIVE CLAIMS DATABASE

EHA Library, Aaron T. Gerds, 4161369

HOSPITALIZATION TIME AND TREATMENT COSTS FOR ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). A SPANISH PETHEMA STUDY

EHA Library, Irene Navarro-Vicente, 4161371

HEALTHCARE RESOURCE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF VARIOUS LINES OF THERAPY AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Adina Estrin, 4161372

FROM SWINE TO SYNTHETIC: A CLIMATE ANALYSIS ON THE SHIFT FROM HEPARIN TO APIXABAN IN POST-OPERATIVE THROMBOEMBOLISM PREVENTION.

EHA Library, Holly Cherniwchan, 4161373

INTEGRATING THE CARBON FOOTPRINT INTO HEALTH TECHNOLOGY ASSESSMENT IN FRANCE: THE EXAMPLE OF THE HEALTHCARE PATHWAY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Caroline Besson, 4161374

UNDERSTANDING THE PREFERENCES OF PEOPLE WITH ACUTE LEUKEMIA FOR DIFFERENT HEALTH OUTCOMES

EHA Library, Samantha Nier, 4161376

INVESTIGATION AND MANAGEMENT OF NEUTROPENIA REFERRALS IN AREA WITH A HIGH PREVALENCE OF AFRO-CARIBBEAN PATIENTS

EHA Library, Priya Sriskandarajah, 4161377

AUTOMATED IMMUNOPHENOTYPIC PROFILING IN AML: A MACHINE LEARNING APPROACH TO EXPEDITE DIAGNOSIS AND DISEASE SUBCLASSIFICATION

EHA Library, Marco Roncador, 4161378

NONINVASIVE LONGITUDINAL DYNAMICAL PET/CT VISUALIZATION OF CAR-T CELLS VIA IN SITU BIOORTHOGONAL LABELING

EHA Library, Zhaozhao Chen, 4161379

ARTIFICIAL INTELLIGENCE-DRIVEN GHOST CYTOMETRY ENABLES LABEL-FREE DETECTION OF LEUKEMIC CELLS AND TREATMENT RESISTANCE PREDICTION IN CHRONIC MYELOID LEUKEMIA

EHA Library, Kohjin Suzuki, 4161380

CELL MARKER ACCORDION: INTERPRETABLE SINGLE-CELL AND SPATIAL OMICS ANNOTATION IN NORMAL AND ABERRANT HEMATOPOIESIS

EHA Library, Giorgia Bucciarelli, 4161381

INTEGRATED GENOME AND EPIGENOME PROFILING OF PEDIATRIC LEUKEMIA USING NANOPORE-BASED TARGETED ADAPTIVE SAMPLING LONG-READ SEQUENCING

EHA Library, Shota Kato, 4161384

AMBIENT AI PLATFORM: AI-POWERED APPLICATION FOR CLINICAL REPORT TRANSCRIPTION ASSISTANCE AND CLINICAL TRIAL PATIENT MANAGEMENT IMPROVEMENT IN HEMATOLOGY

EHA Library, Saverio D'Amico, 4161385

REAL-WORLD POST-VOC EXPERIENCES IN SICKLE CELL DISEASE: INSIGHTS FROM UK PATIENT OUTCOMES, INSIGHTS AND WEARABLE DATA

EHA Library, Kim Summers, 4161396

DEVELOPMENT OF SINGLE-MOLECULE ASSAYS FOR DETECTING BFL1 COMPLEXES TO ENABLE COMPREHENSIVE PROFILING OF THE APOPTOSIS PATHWAY

EHA Library, Hongwon Lee, 4161398

DEVELOPMENT OF AN IN VITRO BIOMARKER PLATFORM FOR DETERMINING BISPECIFIC ANTIBODY EFFICACY IN HAEMATOLOGICAL MALIGNANCIES

EHA Library, Rachel Koldej, 4161399